Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
Jaume Capdevila
Based on 32 articles published since 2010
(Why 32 articles?)
||||
Expertise Level
The expertise of Jaume Capdevila ranks in the
  • Top 0.057%
  • ... of 104,375 published authors worldwide on Pancreatic Neoplasms
  • ... from 2010 through 2020
  • ... based on contributions to 32 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Capdevila, J   ·   Capdevila, Jaume
Work Locations
Details
Most likely:    Vall d'Hebron Research Institut de Recerca      
2019
  • Department of Internal Medicine, Erasmus MC, ENETS Center of Excellence, Erasmus MC Cancer Center, Rotterdam, The Netherlands, · Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 30517944
  • Cell Biology Section, NIDDK, National Institutes of Health, Bethesda, Maryland, · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. · Service de Pathologie, Hôpital Bichat, Paris, France. · Chirurgia del Pancreas, Università Vita e Salute, San Raffaele Hospital IRCCS, Milan, Italy. · Neuroendocrine Unit, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Institute of Pathology, Technische Universität München, Munich, Germany. · Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Oncology, Antwerp University Hospital, Edegem, Belgium. · Institute of Anatomic Pathology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. · Department of Gastroenterology, UKGM Marburg and Philipps University, Marburg, Germany. · Department of Surgery, Philipps University, Marburg, Germany. · Department of Radiology, Institute of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Endocrine Oncology Unit, Department of Medical Sciences, University Hospital, Uppsala, Sweden. · Gastrointestinal and Neuroendocrine Oncology Unit, European Institute of Oncology (IEO), Milan, Italy. · Pubmed 30282083
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Catalan Institute of Oncology (ICO), Bellvitge, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · 12 de Octubre University Hospital, Madrid, Spain. · Marques de Valdecilla University Hospital, Santander, Spain. · Catalan Institute of Oncology (ICO), Badalona, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Consorci Sanitari Terrassa, Terrassa, Spain. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · ProCURE Research Program (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain. · Pubmed 29794066
  • Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain. · Department of Medical Oncology, Hospital Reina Sofía, Córdoba, IMIBIC, CIBERONC, Córdoba, Spain. · Department of Medical Oncology, Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain. · Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, IdiSNA, Pamplona, Spain. · Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville, Spain. · Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VIHO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, IIS imas12, UCM, CNIO, CIBERONC, Av. de Córdoba, s/n, 28041, Madrid, Spain. · Pubmed 30535553
2018
  • Radiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Endocrinology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain. · Radiology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitario Regional y Virgen de la Victoria de Málaga, Malaga, Spain. · Medical Oncology Department and Gastrointestinal and Endocrine Tumor Unit, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Pubmed 29766455
  • Department of Medical Oncology, Institut Català d'Oncologia-IDIBELL-CIBERONC, Universitat de Barcelona, Barcelona, Spain · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Albert Einstein College of Medicine, New York City, New York, USA. · David Geffen School of Medicine and Cedars Sinai Medical Center, Los Angeles, California, USA. · Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. · Department of Digestive Medical Oncology (IUCT-RL), Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · Centre Hospitalier Lyon Sud, Pierre-Bénite, France. · Division of Medical Oncology, S Chiara University Hospital, Pisa, Italy. · Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. · Vall Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Department of Biochemistry, Kazan State Medical University, Kazan, Russia. · Royal Free Hospital, London, United Kingdom. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma S.A.S., Rueil-Malmaison, France. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29242283
  • Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Endocrinology, Complejo Asistencial Universitario de Burgos, Burgos, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospital Universitario Duran i Reynalds, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Department of Medical Oncology, Hospital Universitario la Paz, Madrid, Spain. · Department of Endocrinology, Hospital Universitario la Princesa, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain. · Department of Surgery, Hospital de Donostia, San Sebastian, Spain. · Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. · Department of Oncology, Hospital de Basurto, Bilbao, Spain. · Department of Endocrinology, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain · Instituto de Investigación Hospital 12 de Octubre (i+12), Centro Nacional de Investigacion Oncologica (CNIO), CIBERONC, Universidad Complutense de Madrid (UCM), Madrid, Spain. · Pubmed 29330208
2017
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29143176
  • Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Calle Marqués de los Vélez, s/n, CP 30008, Murcia, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Department of Medical Oncology, La Paz University Hospital, Madrid, Spain. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall D'Hebrón University Hospital, Vall D'Hebrón Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander, Spain. · Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Doce de Octubre University Hospital, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Pubmed 28920153
  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron, Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · ProCURE Research Program, Instituto Catalán de Oncología - IDIBELL, Barcelona, Spain. · Oncology Department, Catalan Institute of Oncology-IDIBELL, Universitat de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. · Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Maimónides Institute of Biomedical Research at Córdoba (IMIBIC); Reina Sofía University Hospital; Department of Cell Biology, Physiology and Immunology, University of Córdoba; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain. · Pubmed 27641330
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX · Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ · Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN · Rodney Pommier, Oregon Health & Science University, Portland, OR · Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany · Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France · Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium · Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland · Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands · Paola Tomassetti, University of Bologna, Bologna, Italy · and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • European Institute of Oncology, Milan, Italy · IRCCS National Tumor Institute, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Careggi University Hospital, Florence, Italy. · The Christie NHS Foundation Trust, Manchester, U.K. · University of Duisburg-Essen, Essen, Germany. · Erasmus MC, Rotterdam, the Netherlands. · University Hospital of Vienna, Vienna, Austria. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, U.S.A. · Dana-Farber Cancer Institute, Boston, MA, U.S.A. · The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, U.S.A. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharma AG, Basel, Switzerland. · Novartis Oncology, Paris, France. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 26851029
  • Oncology Unit. Hospital Clínico y Regional de Málaga, Colonia Santa Inés s/n, Málaga, 29010, Spain. · Oncology Unit. Hospital Universitario La Fe, Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain. · Oncology Unit. Hospital Vall d'Hebron, Pg de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Oncology Unit. Hospital Marqués de Valdecilla, Avda. Valdecilla 25, 39008, Santander, Spain. · Oncology Unit. Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041, Madrid, Spain. · Oncology Unit. Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9.100, 28034, Madrid, Spain. · Pubmed 27821081
2015
  • Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Av. Cordoba km 5.4, 28041, Madrid, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. · Medical Oncology Department, Hospital Universitario Virgen de la Victoria y Hospital Regional Universitario, Málaga, Spain. · Medical Oncology Department, Instituto Catalán de Oncología (ICO), Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Seville, Spain. · Medical Oncology Department, Complejo Hospitalario Universitario, A Coruña, Spain. · Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Endocrinology Department, Hospital Puerta de Hierro, Madrid, Spain. · Nuclear Medicine Department, Clinica Universidad de Navarra, Navarra, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Pubmed 26433592
  • Department of Medical Oncology, Central Asturias University Hospital, C/ Avenida de Roma sn, Oviedo, 33011, Asturias, Spain. · Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia, Spain. · Department of General Surgery, La Princesa University Hospital, Madrid, Spain. · Department of Medical Oncology, Burgos University Hospital, Burgos, Spain. · Department of Medical Oncology, Reina Sofia University Hospital, Córdoba, Spain. · Department of Medical Oncology, Canarias University Hospital, Tenerife, Spain. · Department of Endocrinology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain. · Department of Medical Oncology, Virgen del Rocio University Hospital, Instituto de Biomedicina de Sevilla (IBIS) [Universidad de Sevilla, CSIC, HUVR], Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Sevilla, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26245646
  • Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. Electronic address: · Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Department of Medical Oncology, I + 12 Research Institute, 12 de Octubre University Hospital, Madrid. · Department of Medical Oncology, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla (IBIS) [HUVR, CSIC, University of Seville], Virgen del Rocío University Hospital, Seville. · Department of Medical Oncology, Son Espases Hospital, Palma de Mallorca. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Malaga. · Department of Medical Oncology, Clínico Lozano Blesa University Hospital, Zaragoza. · Department of Medical Oncology, Clínico San Carlos Hospital, Madrid. · Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid. · Tumor Angiogenesis Group, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology Research Laboratory, Ramón y Cajal University Hospital, Madrid. · Department of Pathology, Clínico San Carlos Hospital, Madrid. · Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, ISCIII Center for Biomedical Research on Rare Disease (CIBERER) Madrid, Madrid. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. · Department of Endocrinology, Ramón y Cajal University Hospital, Madrid, Spain. · Pubmed 26063633
2014
  • From Royal Free Hospital, London (M.E.C.) · Charité University Medicine Berlin, Berlin (M.P.) · University of Warmia and Mazury, Olsztyn, Poland (J.B.Ć.) · University of Texas M.D. Anderson Cancer Center, Houston (A.T.P.) · University Hospital, Vienna (M.R.) · Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic (E.S.) · Robert-Debré Hospital, Reims (G.C.), Ipsen, Les Ulis, (A.L., S.M., J.B.), Beaujon Hospital, Clichy (P.R.), and Paris Diderot University, Paris (P.R.) - all in France · Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles (E.M.W.) · Vall d'Hebron University Hospital, Barcelona (J.C.) · Western General Hospital, Edinburgh (L.W.) · and Università Cattolica del Sacro Cuore, Rome (G.R.). · Pubmed 25014687
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Johannes Gutenberg University Mainz, Mainz, Germany. · Charité University Hospital, Berlin, Germany. · Pubmed 25768107
2012
  • Departamento de Oncología Médica, Hospital Universitario Vall d'Hebron, Barcelona, España. · Pubmed 22565119
2011
  • Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22586573
2015
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
Probable:    Universitat Autonoma de Barcelona      
2019
  • Department of Internal Medicine, Erasmus MC, ENETS Center of Excellence, Erasmus MC Cancer Center, Rotterdam, The Netherlands, · Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 30517944
  • Cell Biology Section, NIDDK, National Institutes of Health, Bethesda, Maryland, · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. · Service de Pathologie, Hôpital Bichat, Paris, France. · Chirurgia del Pancreas, Università Vita e Salute, San Raffaele Hospital IRCCS, Milan, Italy. · Neuroendocrine Unit, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Institute of Pathology, Technische Universität München, Munich, Germany. · Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Oncology, Antwerp University Hospital, Edegem, Belgium. · Institute of Anatomic Pathology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. · Department of Gastroenterology, UKGM Marburg and Philipps University, Marburg, Germany. · Department of Surgery, Philipps University, Marburg, Germany. · Department of Radiology, Institute of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Endocrine Oncology Unit, Department of Medical Sciences, University Hospital, Uppsala, Sweden. · Gastrointestinal and Neuroendocrine Oncology Unit, European Institute of Oncology (IEO), Milan, Italy. · Pubmed 30282083
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Catalan Institute of Oncology (ICO), Bellvitge, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · 12 de Octubre University Hospital, Madrid, Spain. · Marques de Valdecilla University Hospital, Santander, Spain. · Catalan Institute of Oncology (ICO), Badalona, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Consorci Sanitari Terrassa, Terrassa, Spain. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · ProCURE Research Program (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain. · Pubmed 29794066
  • Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain. · Department of Medical Oncology, Hospital Reina Sofía, Córdoba, IMIBIC, CIBERONC, Córdoba, Spain. · Department of Medical Oncology, Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain. · Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, IdiSNA, Pamplona, Spain. · Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville, Spain. · Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VIHO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, IIS imas12, UCM, CNIO, CIBERONC, Av. de Córdoba, s/n, 28041, Madrid, Spain. · Pubmed 30535553
2018
  • Radiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Endocrinology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain. · Radiology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitario Regional y Virgen de la Victoria de Málaga, Malaga, Spain. · Medical Oncology Department and Gastrointestinal and Endocrine Tumor Unit, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Pubmed 29766455
  • Department of Medical Oncology, Institut Català d'Oncologia-IDIBELL-CIBERONC, Universitat de Barcelona, Barcelona, Spain · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Albert Einstein College of Medicine, New York City, New York, USA. · David Geffen School of Medicine and Cedars Sinai Medical Center, Los Angeles, California, USA. · Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. · Department of Digestive Medical Oncology (IUCT-RL), Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · Centre Hospitalier Lyon Sud, Pierre-Bénite, France. · Division of Medical Oncology, S Chiara University Hospital, Pisa, Italy. · Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. · Vall Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Department of Biochemistry, Kazan State Medical University, Kazan, Russia. · Royal Free Hospital, London, United Kingdom. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma S.A.S., Rueil-Malmaison, France. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29242283
  • Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Endocrinology, Complejo Asistencial Universitario de Burgos, Burgos, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospital Universitario Duran i Reynalds, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Department of Medical Oncology, Hospital Universitario la Paz, Madrid, Spain. · Department of Endocrinology, Hospital Universitario la Princesa, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain. · Department of Surgery, Hospital de Donostia, San Sebastian, Spain. · Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. · Department of Oncology, Hospital de Basurto, Bilbao, Spain. · Department of Endocrinology, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain · Instituto de Investigación Hospital 12 de Octubre (i+12), Centro Nacional de Investigacion Oncologica (CNIO), CIBERONC, Universidad Complutense de Madrid (UCM), Madrid, Spain. · Pubmed 29330208
2017
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29143176
  • Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Calle Marqués de los Vélez, s/n, CP 30008, Murcia, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Department of Medical Oncology, La Paz University Hospital, Madrid, Spain. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall D'Hebrón University Hospital, Vall D'Hebrón Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander, Spain. · Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Doce de Octubre University Hospital, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Pubmed 28920153
  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron, Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · ProCURE Research Program, Instituto Catalán de Oncología - IDIBELL, Barcelona, Spain. · Oncology Department, Catalan Institute of Oncology-IDIBELL, Universitat de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. · Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Maimónides Institute of Biomedical Research at Córdoba (IMIBIC); Reina Sofía University Hospital; Department of Cell Biology, Physiology and Immunology, University of Córdoba; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain. · Pubmed 27641330
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX · Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ · Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN · Rodney Pommier, Oregon Health & Science University, Portland, OR · Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany · Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France · Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium · Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland · Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands · Paola Tomassetti, University of Bologna, Bologna, Italy · and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • European Institute of Oncology, Milan, Italy · IRCCS National Tumor Institute, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Careggi University Hospital, Florence, Italy. · The Christie NHS Foundation Trust, Manchester, U.K. · University of Duisburg-Essen, Essen, Germany. · Erasmus MC, Rotterdam, the Netherlands. · University Hospital of Vienna, Vienna, Austria. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, U.S.A. · Dana-Farber Cancer Institute, Boston, MA, U.S.A. · The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, U.S.A. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharma AG, Basel, Switzerland. · Novartis Oncology, Paris, France. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 26851029
  • Oncology Unit. Hospital Clínico y Regional de Málaga, Colonia Santa Inés s/n, Málaga, 29010, Spain. · Oncology Unit. Hospital Universitario La Fe, Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain. · Oncology Unit. Hospital Vall d'Hebron, Pg de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Oncology Unit. Hospital Marqués de Valdecilla, Avda. Valdecilla 25, 39008, Santander, Spain. · Oncology Unit. Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041, Madrid, Spain. · Oncology Unit. Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9.100, 28034, Madrid, Spain. · Pubmed 27821081
2015
  • Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Av. Cordoba km 5.4, 28041, Madrid, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. · Medical Oncology Department, Hospital Universitario Virgen de la Victoria y Hospital Regional Universitario, Málaga, Spain. · Medical Oncology Department, Instituto Catalán de Oncología (ICO), Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Seville, Spain. · Medical Oncology Department, Complejo Hospitalario Universitario, A Coruña, Spain. · Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Endocrinology Department, Hospital Puerta de Hierro, Madrid, Spain. · Nuclear Medicine Department, Clinica Universidad de Navarra, Navarra, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Pubmed 26433592
  • Department of Medical Oncology, Central Asturias University Hospital, C/ Avenida de Roma sn, Oviedo, 33011, Asturias, Spain. · Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia, Spain. · Department of General Surgery, La Princesa University Hospital, Madrid, Spain. · Department of Medical Oncology, Burgos University Hospital, Burgos, Spain. · Department of Medical Oncology, Reina Sofia University Hospital, Córdoba, Spain. · Department of Medical Oncology, Canarias University Hospital, Tenerife, Spain. · Department of Endocrinology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain. · Department of Medical Oncology, Virgen del Rocio University Hospital, Instituto de Biomedicina de Sevilla (IBIS) [Universidad de Sevilla, CSIC, HUVR], Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Sevilla, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26245646
  • Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. Electronic address: · Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Department of Medical Oncology, I + 12 Research Institute, 12 de Octubre University Hospital, Madrid. · Department of Medical Oncology, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla (IBIS) [HUVR, CSIC, University of Seville], Virgen del Rocío University Hospital, Seville. · Department of Medical Oncology, Son Espases Hospital, Palma de Mallorca. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Malaga. · Department of Medical Oncology, Clínico Lozano Blesa University Hospital, Zaragoza. · Department of Medical Oncology, Clínico San Carlos Hospital, Madrid. · Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid. · Tumor Angiogenesis Group, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology Research Laboratory, Ramón y Cajal University Hospital, Madrid. · Department of Pathology, Clínico San Carlos Hospital, Madrid. · Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, ISCIII Center for Biomedical Research on Rare Disease (CIBERER) Madrid, Madrid. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. · Department of Endocrinology, Ramón y Cajal University Hospital, Madrid, Spain. · Pubmed 26063633
2014
  • From Royal Free Hospital, London (M.E.C.) · Charité University Medicine Berlin, Berlin (M.P.) · University of Warmia and Mazury, Olsztyn, Poland (J.B.Ć.) · University of Texas M.D. Anderson Cancer Center, Houston (A.T.P.) · University Hospital, Vienna (M.R.) · Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic (E.S.) · Robert-Debré Hospital, Reims (G.C.), Ipsen, Les Ulis, (A.L., S.M., J.B.), Beaujon Hospital, Clichy (P.R.), and Paris Diderot University, Paris (P.R.) - all in France · Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles (E.M.W.) · Vall d'Hebron University Hospital, Barcelona (J.C.) · Western General Hospital, Edinburgh (L.W.) · and Università Cattolica del Sacro Cuore, Rome (G.R.). · Pubmed 25014687
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Johannes Gutenberg University Mainz, Mainz, Germany. · Charité University Hospital, Berlin, Germany. · Pubmed 25768107
2012
  • Departamento de Oncología Médica, Hospital Universitario Vall d'Hebron, Barcelona, España. · Pubmed 22565119
2011
  • Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22586573
2015
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
Probable:    Centro Medico Teknon      
2019
  • Servicio de Aparato Digestivo, Hospital Sanitas CIMA, Barcelona, España; Unidad de Gastroenterología y Hepatología, Hospital Universitario Teknon Quirón Salud, Barcelona, España; Facultat de Ciencias de la Salud, Universitat Oberta de Catalunya (UOC), Barcelona, España. · Servicio de Cirugía General-Aparato Digestivo, Hospital Universitario Teknon Quirón Salud, Barcelona, España. · Instituto Oncológico, Hospital Universitario Teknon Quirón Salud, Barcelona, España. · Unidad de Investigación Clínica, Hospital CIMA Sanitas, Barcelona, España. Electronic address: · Pubmed 29858120
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 32 total) written by Jaume Capdevila about Pancreatic Neoplasms:

  • Unmet Needs in the Field of Neuroendocrine Neoplasms of the Gastrointestinal Tract, Pancreas, and Respiratory System: Reports by the ENETS Group. 2019
  • Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms. 2019
  • Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study. 2019
  • SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2018). 2019
  • Detection of pancreatic neuroendocrine tumors: 23 years of experience. 2019
  • Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors. 2018
  • Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors. 2018
  • Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). 2018
  • The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors. 2017
  • Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors. 2017
Show List of Full Article Records
Google Searches

Learn more about Jaume Capdevila using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Vall d'Hebron Research Institut de Recerca
Universitat Autonoma de Barcelona
Centro Medico Teknon
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Vall d'Hebron Research Institut de Recerca
2019
  • Department of Internal Medicine, Erasmus MC, ENETS Center of Excellence, Erasmus MC Cancer Center, Rotterdam, The Netherlands, · Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 30517944
  • Cell Biology Section, NIDDK, National Institutes of Health, Bethesda, Maryland, · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. · Service de Pathologie, Hôpital Bichat, Paris, France. · Chirurgia del Pancreas, Università Vita e Salute, San Raffaele Hospital IRCCS, Milan, Italy. · Neuroendocrine Unit, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Institute of Pathology, Technische Universität München, Munich, Germany. · Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Oncology, Antwerp University Hospital, Edegem, Belgium. · Institute of Anatomic Pathology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. · Department of Gastroenterology, UKGM Marburg and Philipps University, Marburg, Germany. · Department of Surgery, Philipps University, Marburg, Germany. · Department of Radiology, Institute of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Endocrine Oncology Unit, Department of Medical Sciences, University Hospital, Uppsala, Sweden. · Gastrointestinal and Neuroendocrine Oncology Unit, European Institute of Oncology (IEO), Milan, Italy. · Pubmed 30282083
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Catalan Institute of Oncology (ICO), Bellvitge, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · 12 de Octubre University Hospital, Madrid, Spain. · Marques de Valdecilla University Hospital, Santander, Spain. · Catalan Institute of Oncology (ICO), Badalona, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Consorci Sanitari Terrassa, Terrassa, Spain. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · ProCURE Research Program (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain. · Pubmed 29794066
  • Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain. · Department of Medical Oncology, Hospital Reina Sofía, Córdoba, IMIBIC, CIBERONC, Córdoba, Spain. · Department of Medical Oncology, Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain. · Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, IdiSNA, Pamplona, Spain. · Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville, Spain. · Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VIHO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, IIS imas12, UCM, CNIO, CIBERONC, Av. de Córdoba, s/n, 28041, Madrid, Spain. · Pubmed 30535553
2018
  • Radiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Endocrinology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain. · Radiology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitario Regional y Virgen de la Victoria de Málaga, Malaga, Spain. · Medical Oncology Department and Gastrointestinal and Endocrine Tumor Unit, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Pubmed 29766455
  • Department of Medical Oncology, Institut Català d'Oncologia-IDIBELL-CIBERONC, Universitat de Barcelona, Barcelona, Spain · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Albert Einstein College of Medicine, New York City, New York, USA. · David Geffen School of Medicine and Cedars Sinai Medical Center, Los Angeles, California, USA. · Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. · Department of Digestive Medical Oncology (IUCT-RL), Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · Centre Hospitalier Lyon Sud, Pierre-Bénite, France. · Division of Medical Oncology, S Chiara University Hospital, Pisa, Italy. · Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. · Vall Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Department of Biochemistry, Kazan State Medical University, Kazan, Russia. · Royal Free Hospital, London, United Kingdom. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma S.A.S., Rueil-Malmaison, France. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29242283
  • Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Endocrinology, Complejo Asistencial Universitario de Burgos, Burgos, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospital Universitario Duran i Reynalds, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Department of Medical Oncology, Hospital Universitario la Paz, Madrid, Spain. · Department of Endocrinology, Hospital Universitario la Princesa, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain. · Department of Surgery, Hospital de Donostia, San Sebastian, Spain. · Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. · Department of Oncology, Hospital de Basurto, Bilbao, Spain. · Department of Endocrinology, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain · Instituto de Investigación Hospital 12 de Octubre (i+12), Centro Nacional de Investigacion Oncologica (CNIO), CIBERONC, Universidad Complutense de Madrid (UCM), Madrid, Spain. · Pubmed 29330208
2017
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29143176
  • Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Calle Marqués de los Vélez, s/n, CP 30008, Murcia, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Department of Medical Oncology, La Paz University Hospital, Madrid, Spain. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall D'Hebrón University Hospital, Vall D'Hebrón Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander, Spain. · Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Doce de Octubre University Hospital, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Pubmed 28920153
  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron, Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · ProCURE Research Program, Instituto Catalán de Oncología - IDIBELL, Barcelona, Spain. · Oncology Department, Catalan Institute of Oncology-IDIBELL, Universitat de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. · Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Maimónides Institute of Biomedical Research at Córdoba (IMIBIC); Reina Sofía University Hospital; Department of Cell Biology, Physiology and Immunology, University of Córdoba; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain. · Pubmed 27641330
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX · Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ · Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN · Rodney Pommier, Oregon Health & Science University, Portland, OR · Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany · Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France · Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium · Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland · Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands · Paola Tomassetti, University of Bologna, Bologna, Italy · and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • European Institute of Oncology, Milan, Italy · IRCCS National Tumor Institute, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Careggi University Hospital, Florence, Italy. · The Christie NHS Foundation Trust, Manchester, U.K. · University of Duisburg-Essen, Essen, Germany. · Erasmus MC, Rotterdam, the Netherlands. · University Hospital of Vienna, Vienna, Austria. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, U.S.A. · Dana-Farber Cancer Institute, Boston, MA, U.S.A. · The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, U.S.A. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharma AG, Basel, Switzerland. · Novartis Oncology, Paris, France. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 26851029
  • Oncology Unit. Hospital Clínico y Regional de Málaga, Colonia Santa Inés s/n, Málaga, 29010, Spain. · Oncology Unit. Hospital Universitario La Fe, Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain. · Oncology Unit. Hospital Vall d'Hebron, Pg de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Oncology Unit. Hospital Marqués de Valdecilla, Avda. Valdecilla 25, 39008, Santander, Spain. · Oncology Unit. Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041, Madrid, Spain. · Oncology Unit. Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9.100, 28034, Madrid, Spain. · Pubmed 27821081
2015
  • Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Av. Cordoba km 5.4, 28041, Madrid, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. · Medical Oncology Department, Hospital Universitario Virgen de la Victoria y Hospital Regional Universitario, Málaga, Spain. · Medical Oncology Department, Instituto Catalán de Oncología (ICO), Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Seville, Spain. · Medical Oncology Department, Complejo Hospitalario Universitario, A Coruña, Spain. · Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Endocrinology Department, Hospital Puerta de Hierro, Madrid, Spain. · Nuclear Medicine Department, Clinica Universidad de Navarra, Navarra, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Pubmed 26433592
  • Department of Medical Oncology, Central Asturias University Hospital, C/ Avenida de Roma sn, Oviedo, 33011, Asturias, Spain. · Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia, Spain. · Department of General Surgery, La Princesa University Hospital, Madrid, Spain. · Department of Medical Oncology, Burgos University Hospital, Burgos, Spain. · Department of Medical Oncology, Reina Sofia University Hospital, Córdoba, Spain. · Department of Medical Oncology, Canarias University Hospital, Tenerife, Spain. · Department of Endocrinology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain. · Department of Medical Oncology, Virgen del Rocio University Hospital, Instituto de Biomedicina de Sevilla (IBIS) [Universidad de Sevilla, CSIC, HUVR], Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Sevilla, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26245646
  • Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. Electronic address: · Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Department of Medical Oncology, I + 12 Research Institute, 12 de Octubre University Hospital, Madrid. · Department of Medical Oncology, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla (IBIS) [HUVR, CSIC, University of Seville], Virgen del Rocío University Hospital, Seville. · Department of Medical Oncology, Son Espases Hospital, Palma de Mallorca. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Malaga. · Department of Medical Oncology, Clínico Lozano Blesa University Hospital, Zaragoza. · Department of Medical Oncology, Clínico San Carlos Hospital, Madrid. · Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid. · Tumor Angiogenesis Group, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology Research Laboratory, Ramón y Cajal University Hospital, Madrid. · Department of Pathology, Clínico San Carlos Hospital, Madrid. · Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, ISCIII Center for Biomedical Research on Rare Disease (CIBERER) Madrid, Madrid. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. · Department of Endocrinology, Ramón y Cajal University Hospital, Madrid, Spain. · Pubmed 26063633
2014
  • From Royal Free Hospital, London (M.E.C.) · Charité University Medicine Berlin, Berlin (M.P.) · University of Warmia and Mazury, Olsztyn, Poland (J.B.Ć.) · University of Texas M.D. Anderson Cancer Center, Houston (A.T.P.) · University Hospital, Vienna (M.R.) · Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic (E.S.) · Robert-Debré Hospital, Reims (G.C.), Ipsen, Les Ulis, (A.L., S.M., J.B.), Beaujon Hospital, Clichy (P.R.), and Paris Diderot University, Paris (P.R.) - all in France · Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles (E.M.W.) · Vall d'Hebron University Hospital, Barcelona (J.C.) · Western General Hospital, Edinburgh (L.W.) · and Università Cattolica del Sacro Cuore, Rome (G.R.). · Pubmed 25014687
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Johannes Gutenberg University Mainz, Mainz, Germany. · Charité University Hospital, Berlin, Germany. · Pubmed 25768107
2012
  • Departamento de Oncología Médica, Hospital Universitario Vall d'Hebron, Barcelona, España. · Pubmed 22565119
2011
  • Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22586573
2015
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
Universitat Autonoma de Barcelona
2019
  • Department of Internal Medicine, Erasmus MC, ENETS Center of Excellence, Erasmus MC Cancer Center, Rotterdam, The Netherlands, · Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain. · Pubmed 30517944
  • Cell Biology Section, NIDDK, National Institutes of Health, Bethesda, Maryland, · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain. · Service de Pathologie, Hôpital Bichat, Paris, France. · Chirurgia del Pancreas, Università Vita e Salute, San Raffaele Hospital IRCCS, Milan, Italy. · Neuroendocrine Unit, Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. · Institute of Pathology, Technische Universität München, Munich, Germany. · Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Oncology, Antwerp University Hospital, Edegem, Belgium. · Institute of Anatomic Pathology, Policlinico A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy. · Department of Gastroenterology, UKGM Marburg and Philipps University, Marburg, Germany. · Department of Surgery, Philipps University, Marburg, Germany. · Department of Radiology, Institute of Surgical Sciences, Uppsala University, Uppsala, Sweden. · Endocrine Oncology Unit, Department of Medical Sciences, University Hospital, Uppsala, Sweden. · Gastrointestinal and Neuroendocrine Oncology Unit, European Institute of Oncology (IEO), Milan, Italy. · Pubmed 30282083
  • Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain · Catalan Institute of Oncology (ICO), Bellvitge, Barcelona, Spain. · La Paz University Hospital, Madrid, Spain. · 12 de Octubre University Hospital, Madrid, Spain. · Marques de Valdecilla University Hospital, Santander, Spain. · Catalan Institute of Oncology (ICO), Badalona, Spain. · Miguel Servet University Hospital, Zaragoza, Spain. · Consorci Sanitari Terrassa, Terrassa, Spain. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · ProCURE Research Program (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain. · Pubmed 29794066
  • Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain. · Department of Medical Oncology, Hospital Reina Sofía, Córdoba, IMIBIC, CIBERONC, Córdoba, Spain. · Department of Medical Oncology, Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain. · Department of Medical Oncology, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, IdiSNA, Pamplona, Spain. · Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. · Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina, Seville, Spain. · Department of Medical Oncology, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VIHO), Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Universitario 12 de Octubre, IIS imas12, UCM, CNIO, CIBERONC, Av. de Córdoba, s/n, 28041, Madrid, Spain. · Pubmed 30535553
2018
  • Radiology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Endocrinology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Nuclear Medicine Department, Clínica Universidad de Navarra, Pamplona, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, A Coruña, Spain. · Radiology Department, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitario Regional y Virgen de la Victoria de Málaga, Malaga, Spain. · Medical Oncology Department and Gastrointestinal and Endocrine Tumor Unit, Hospital Universitario Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035, Barcelona, Spain. · Pubmed 29766455
  • Department of Medical Oncology, Institut Català d'Oncologia-IDIBELL-CIBERONC, Universitat de Barcelona, Barcelona, Spain · Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. · Albert Einstein College of Medicine, New York City, New York, USA. · David Geffen School of Medicine and Cedars Sinai Medical Center, Los Angeles, California, USA. · Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. · Department of Digestive Medical Oncology (IUCT-RL), Centre Hospitalier Universitaire de Toulouse, Toulouse, France. · Centre Hospitalier Lyon Sud, Pierre-Bénite, France. · Division of Medical Oncology, S Chiara University Hospital, Pisa, Italy. · Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands. · Vall Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Beatson West of Scotland Cancer Centre, Glasgow, Scotland. · University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. · Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Department of Biochemistry, Kazan State Medical University, Kazan, Russia. · Royal Free Hospital, London, United Kingdom. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA. · Novartis Pharma S.A.S., Rueil-Malmaison, France. · The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29242283
  • Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain. · Department of Hematology & Medical Oncology, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain. · Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain. · Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain. · Department of Pathology, Hospital Universitario de Fuenlabrada, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain. · Department of Endocrinology, Complejo Asistencial Universitario de Burgos, Burgos, Spain. · Department of Medical Oncology, Instituto Catalán de Oncología, Hospital Universitario Duran i Reynalds, Barcelona, Spain. · Department of Medical Oncology, Hospital Universitario Miguel Servet, Zaragoza, Spain. · Department of Medical Oncology, Hospital Universitario la Paz, Madrid, Spain. · Department of Endocrinology, Hospital Universitario la Princesa, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain. · Department of Surgery, Hospital de Donostia, San Sebastian, Spain. · Department of Medical Oncology, Hospital Universitario de Canarias, Tenerife, Spain. · Department of Oncology, Hospital de Basurto, Bilbao, Spain. · Department of Endocrinology, Hospital Clínico Universitario San Carlos, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. · Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. · Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. · Department of Medical Oncology, Hospital Universitario Doce de Octubre, Madrid, Spain · Instituto de Investigación Hospital 12 de Octubre (i+12), Centro Nacional de Investigacion Oncologica (CNIO), CIBERONC, Universidad Complutense de Madrid (UCM), Madrid, Spain. · Pubmed 29330208
2017
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Vall d'Hebron University Hospital, Barcelona, Spain. · Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · Pubmed 29143176
  • Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Calle Marqués de los Vélez, s/n, CP 30008, Murcia, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Department of Medical Oncology, La Paz University Hospital, Madrid, Spain. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall D'Hebrón University Hospital, Vall D'Hebrón Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Marqués de Valdecilla University Hospital, Santander, Spain. · Department of Medical Oncology, Institut Català d'Oncologia, L'Hospitalet de Llobregat, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Doce de Octubre University Hospital, center affiliated with the Red Temática de Investigación Cooperativa en Cáncer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Pubmed 28920153
  • Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron, Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. · ProCURE Research Program, Instituto Catalán de Oncología - IDIBELL, Barcelona, Spain. · Oncology Department, Catalan Institute of Oncology-IDIBELL, Universitat de Barcelona, Barcelona, Spain. · Oncology Department, Hospital Universitario 12 de Octubre, Madrid, Spain. · Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. · Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Madrid, Spain. · Department of Medical Oncology, Central Asturias University Hospital, Oviedo, Spain. · Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. · Maimónides Institute of Biomedical Research at Córdoba (IMIBIC); Reina Sofía University Hospital; Department of Cell Biology, Physiology and Immunology, University of Córdoba; CIBER Fisiopatología de la Obesidad y Nutrición, Córdoba, Spain. · Pubmed 27641330
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX · Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ · Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN · Rodney Pommier, Oregon Health & Science University, Portland, OR · Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany · Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France · Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium · Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland · Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands · Paola Tomassetti, University of Bologna, Bologna, Italy · and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • European Institute of Oncology, Milan, Italy · IRCCS National Tumor Institute, Milan, Italy. · Institut Gustave Roussy, Villejuif, France. · Careggi University Hospital, Florence, Italy. · The Christie NHS Foundation Trust, Manchester, U.K. · University of Duisburg-Essen, Essen, Germany. · Erasmus MC, Rotterdam, the Netherlands. · University Hospital of Vienna, Vienna, Austria. · Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY, U.S.A. · Dana-Farber Cancer Institute, Boston, MA, U.S.A. · The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH, U.S.A. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharma AG, Basel, Switzerland. · Novartis Oncology, Paris, France. · University Hospitals Leuven, Leuven, Belgium. · Pubmed 26851029
  • Oncology Unit. Hospital Clínico y Regional de Málaga, Colonia Santa Inés s/n, Málaga, 29010, Spain. · Oncology Unit. Hospital Universitario La Fe, Avda. de Fernando Abril Martorell 106, 46026, Valencia, Spain. · Oncology Unit. Hospital Vall d'Hebron, Pg de la Vall d'Hebron 119-129, 08035, Barcelona, Spain. · Oncology Unit. Hospital Marqués de Valdecilla, Avda. Valdecilla 25, 39008, Santander, Spain. · Oncology Unit. Hospital Universitario 12 de Octubre, Avda. de Córdoba s/n, 28041, Madrid, Spain. · Oncology Unit. Hospital Universitario Ramón y Cajal, Ctra. de Colmenar Viejo km. 9.100, 28034, Madrid, Spain. · Pubmed 27821081
2015
  • Medical Oncology Department, Hospital Universitario Doce de Octubre, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Av. Cordoba km 5.4, 28041, Madrid, Spain. · Radiology Department, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain. · Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. · Medical Oncology Department, Hospital Universitario Virgen de la Victoria y Hospital Regional Universitario, Málaga, Spain. · Medical Oncology Department, Instituto Catalán de Oncología (ICO), Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Seville, Spain. · Medical Oncology Department, Complejo Hospitalario Universitario, A Coruña, Spain. · Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain. · Medical Oncology Department, Hospital Vall d'Hebron, Center affiliated to the Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Endocrinology Department, Hospital Puerta de Hierro, Madrid, Spain. · Nuclear Medicine Department, Clinica Universidad de Navarra, Navarra, Spain. · Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. · Pubmed 26433592
  • Department of Medical Oncology, Central Asturias University Hospital, C/ Avenida de Roma sn, Oviedo, 33011, Asturias, Spain. · Department of Hematology and Medical Oncology, Morales Meseguer University Hospital, Murcia, Spain. · Department of General Surgery, La Princesa University Hospital, Madrid, Spain. · Department of Medical Oncology, Burgos University Hospital, Burgos, Spain. · Department of Medical Oncology, Reina Sofia University Hospital, Córdoba, Spain. · Department of Medical Oncology, Canarias University Hospital, Tenerife, Spain. · Department of Endocrinology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain. · Department of Medical Oncology, Virgen del Rocio University Hospital, Instituto de Biomedicina de Sevilla (IBIS) [Universidad de Sevilla, CSIC, HUVR], Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Sevilla, Spain. · Department of Endocrinology, Puerta de Hierro University Hospital, Madrid, Spain. · Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Center affiliated with the Red Temática de Investigación Cooperativa en Cancer (RTICC), Instituto Carlos III, Spanish Ministry of Science and Innovation, Barcelona, Spain. · Department of Medical Oncology, Ramon y Cajal University Hospital, Madrid, Spain. · Pubmed 26245646
  • Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. Electronic address: · Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona. · Department of Medical Oncology, I + 12 Research Institute, 12 de Octubre University Hospital, Madrid. · Department of Medical Oncology, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology, Instituto de Biomedicina de Sevilla (IBIS) [HUVR, CSIC, University of Seville], Virgen del Rocío University Hospital, Seville. · Department of Medical Oncology, Son Espases Hospital, Palma de Mallorca. · Department of Medical Oncology, Virgen de la Victoria University Hospital, Malaga. · Department of Medical Oncology, Clínico Lozano Blesa University Hospital, Zaragoza. · Department of Medical Oncology, Clínico San Carlos Hospital, Madrid. · Department of Medical Oncology, Centro Integral Oncológico Clara Campal, Madrid. · Tumor Angiogenesis Group, IDIBELL, Catalan Institute of Oncology L'Hospitalet, Barcelona. · Department of Medical Oncology Research Laboratory, Ramón y Cajal University Hospital, Madrid. · Department of Pathology, Clínico San Carlos Hospital, Madrid. · Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center, ISCIII Center for Biomedical Research on Rare Disease (CIBERER) Madrid, Madrid. · Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid. · Department of Endocrinology, Ramón y Cajal University Hospital, Madrid, Spain. · Pubmed 26063633
2014
  • From Royal Free Hospital, London (M.E.C.) · Charité University Medicine Berlin, Berlin (M.P.) · University of Warmia and Mazury, Olsztyn, Poland (J.B.Ć.) · University of Texas M.D. Anderson Cancer Center, Houston (A.T.P.) · University Hospital, Vienna (M.R.) · Department of Oncology of the First Faculty of Medicine and General Teaching Hospital, Prague, Czech Republic (E.S.) · Robert-Debré Hospital, Reims (G.C.), Ipsen, Les Ulis, (A.L., S.M., J.B.), Beaujon Hospital, Clichy (P.R.), and Paris Diderot University, Paris (P.R.) - all in France · Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles (E.M.W.) · Vall d'Hebron University Hospital, Barcelona (J.C.) · Western General Hospital, Edinburgh (L.W.) · and Università Cattolica del Sacro Cuore, Rome (G.R.). · Pubmed 25014687
  • Vall d'Hebron University Hospital, Barcelona, Spain. · Johannes Gutenberg University Mainz, Mainz, Germany. · Charité University Hospital, Berlin, Germany. · Pubmed 25768107
2012
  • Departamento de Oncología Médica, Hospital Universitario Vall d'Hebron, Barcelona, España. · Pubmed 22565119
2011
  • Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain. · Pubmed 22586573
2015
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
Centro Medico Teknon
2019
  • Servicio de Aparato Digestivo, Hospital Sanitas CIMA, Barcelona, España; Unidad de Gastroenterología y Hepatología, Hospital Universitario Teknon Quirón Salud, Barcelona, España; Facultat de Ciencias de la Salud, Universitat Oberta de Catalunya (UOC), Barcelona, España. · Servicio de Cirugía General-Aparato Digestivo, Hospital Universitario Teknon Quirón Salud, Barcelona, España. · Instituto Oncológico, Hospital Universitario Teknon Quirón Salud, Barcelona, España. · Unidad de Investigación Clínica, Hospital CIMA Sanitas, Barcelona, España. Electronic address: · Pubmed 29858120
University of Texas Houston
2016
  • Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France · Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France. · Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France Royal Free HospitalLondon, UKCharité University Medicine BerlinBerlin, GermanyUniversity of Warmia and MazuryOlsztyn, PolandUniversity of Texas MD Anderson Cancer CenterHouston, Texas, USAUniversity HospitalVienna, AustriaDepartment of Oncology of the First Faculty of Medicine and General Teaching HospitalPrague, Czech RepublicRobert-Debré HospitalReims, FranceMarkey Cancer CenterUniversity of Kentucky, Lexington, Kentucky, USAVall d'Hebron University HospitalBarcelona, SpainWestern General HospitalEdinburgh, UKUniversità Cattolica del Sacro CuoreRome, ItalyIpsenLes Ulis, FranceIpsenBasking Ridge, New Jersey, USABeaujon HospitalClichy, FranceParis Diderot UniversityParis, France. · Pubmed 26743120
2015
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
2011
  • University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21306238
14 Other Locations Show
Yearly article counts 05346531221
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.